Atopic dermatitis is characterized by increased skin innervation. The expression of neurotrophin-4 is enhanced in the epidermal keratinocytes of lesions with atopic dermatitis and may be related to hyperinnervation in these lesions. Prostaglandin E 2 (PGE 2 ) levels are increased in lesions with atopic dermatitis; thus, PGE 2 may be involved in the development of this disease. We examined the in vitro effects of PGE 2 on neurotrophin-4 production in human keratinocytes. PGE 2 and EP1/EP3 agonist sulprostone increased neurotrophin-4 secretion and mRNA levels without altering its mRNA stability. Antisense Sp1 oligodeoxynucleotide and Sp1 inhibitor mithramycin A suppressed PGE 2 and sulprostone-induced neurotrophin-4 expression, indicating the requirement for Sp1 for expression. PGE 2 or sulprostone markedly enhanced the phosphorylation, DNA binding, and transcriptional activity of Sp1 and modestly increased Sp1 mRNA and protein levels. PGE 2 or sulprostone induced the membrane translocation of protein kinase C␣ and the phosphorylation of extracellular signal-regulated kinase (ERK). PGE 2 -induced increases in neurotrophin-4 expression, Sp1 transcriptional and DNA-binding activity, Sp1 mRNA and protein levels, and ERK phosphorylation were suppressed by antisense EP3 oligodeoxynucleotide, inhibitors of phosphatidylinositol-specific phospholipase C, conventional protein kinase C, and mitogen-activated protein kinase/ERK kinase 1 (MEK1). These results suggest that PGE 2 enhances neurotrophin-4 production by activating Sp1 via the EP3/phosphatidylinositolspecific phospholipase C/protein kinase C␣/MEK1/ERK pathway. PGE 2 may promote innervation in skin lesions with atopic dermatitis via the induction of neurotrophin-4.
Sp1 mRNA and protein levels. PGE 2 or sulprostone induced the membrane translocation of protein kinase C␣ and the phosphorylation of extracellular signal-regulated kinase (ERK). PGE 2 -induced increases in neurotrophin-4 expression, Sp1 transcriptional and DNA-binding activity, Sp1 mRNA and protein levels, and ERK phosphorylation were suppressed by antisense EP3 oligodeoxynucleotide, inhibitors of phosphatidylinositol-specific phospholipase C, conventional protein kinase C, and mitogen-activated protein kinase/ERK kinase 1 (MEK1). These results suggest that PGE 2 enhances neurotrophin-4 production by activating Sp1 via the EP3/phosphatidylinositolspecific phospholipase C/protein kinase C␣/MEK1/ERK pathway. PGE 2 may promote innervation in skin lesions with atopic dermatitis via the induction of neurotrophin-4.
Chronic inflammatory skin lesions such as prurigo in atopic dermatitis are characterized clinically by intense pruritus and histologically by increased nerve fibers (Sugiura et al., 1997; Grewe et al., 2000) . In particular, free sensory nerve endings that act as receptors of pruritic sensation are frequently increased at the dermoepidermal junction of lesions with atopic dermatitis (Sugiura et al., 1997) . The hyperinnervation in these skin lesions may be related to the locally enhanced production of neurotrophic factors (Grewe et al., 2000) . It has recently been reported that the expression of a neurotrophic factor, neurotrophin-4 (NT-4), is markedly enhanced in the epidermal keratinocytes of prurigo lesions with atopic dermatitis (Grewe et al., 2000) . NT-4 binds highaffinity tyrosine kinase receptor trkB and low-affinity p75 neurotrophin receptor (p75NTR) on neural cells (Barbacid, 1994) . Another tyrosine kinase receptor, trkA, also serves as NT-4 receptor with lower efficiency (Barbacid, 1994) . The activation of trkB stimulates phosphatidylinositol 3-kinase or extracellular signal-regulated kinase (ERK) (Segal and Greenberg, 1996) , whereas the activation of p75NTR stimulates nuclear factor B in neurons (Carter et al., 1996) . The activation of trkB alone or together with p75NTR by NT-4 can thus promote the survival and differentiation of neurons (Segal and Greenberg, 1996) , which may induce sensory nerve sprouting in atopic prurigo lesions. trkB or p75NTR is expressed on several immune cells, such as eosinophils, mast cells, macrophages, and T cells (Nassenstein et al., 2003) . NT-4 promotes survival and CD69 expression in allergenstimulated endobronchial eosinophils in allergic asthma (Nassenstein et al., 2003) . In lesions with atopic dermatitis, keratinocyte-derived NT-4 may modulate the survival or function of immune cells and may serve as a substrate that links the immune and the nervous systems.
A lipid mediator, prostaglandin E 2 (PGE 2 ), is produced by a variety of cells in the skin, such as mast cells, macrophages, dendritic cells, and keratinocytes . PGE 2 may play either a pro-or an anti-inflammatory role in the skin that is dependent on the target cell type or activation status; the intradermal injection of PGE 2 induces local vasodilation and wheals (Greaves and Camp, 1988) . On the other hand, PGE 2 enhances the production of immunosuppressive type 2 cytokines, such as interleukin-4 or interleukin-10, and thus suppresses the induction of delayed-type hypersensitivity in the skin (Shreedhar et al., 1998) . PGE 2 levels are elevated in atopic skin lesions (Reilly et al., 2000) . Thus, it is anticipated that PGE 2 regulates NT-4 production by keratinocytes in lesions with atopic dermatitis. However, the effects of PGE 2 on NT-4 production have not been precisely examined.
Prostaglandin E 2 binds four different G-protein-coupled receptors, EP1 to EP4, on the cell surface (Negishi et al., 1995) . Keratinocytes express all four receptors with much higher levels of EP2 and EP3 than those of EP1 and EP4 . The activation of EP1 or EP3 on keratinocytes induces intracellular Ca 2ϩ signal via the activation of phosphatidylinositol-specific phospholipase C (PI-PLC), whereas the activation of EP2 or EP4 generates a cyclic AMP signal . Because the activation of PI-PLC generates diacylglycerol that stimulates protein kinase C (PKC) (Negishi et al., 1990) , PGE 2 stimulates PKC via EP1 or EP3 in rat growth zone chondrocytes (Sylvia et al., 2001) or bovine adrenal chromaffin cells (Negishi et al., 1990) . PGE 2 also activates ERK that is dependent on or independent of PKC via EP1 or EP3 in human lung cancer A549 cells (Yano et al., 2002) and rat mesangial cells (Suganami et al., 2001) .
In this study, we investigated the in vitro effects of PGE 2 on NT-4 production by human keratinocytes. We found that PGE 2 has a stimulatory effect and further analyzed the mechanism of the effects.
Materials and Methods
Reagents. PGE 2 , prostaglandin E 1 alcohol (1-OH PGE 1 ), and sulprostone were purchased from Cayman Chemical (Ann Arbor, MI). H-89, cycloheximide, mithramycin A, curcumin, and actinomycin D were purchased from Sigma Chemical Co. (St Louis, MO). U73122, PD98059, Gö6976, and rottlerin were obtained from Calbiochem (La Jolla, CA).
Culture of Keratinocytes. Human neonatal foreskin keratinocytes were cultured in a serum-free KGM medium (Cambrex Bio Science Walkersville, Walkersville, MD) consisting of keratinocyte basal medium (KBM) supplemented with 0.5 g/ml hydrocortisone, 5 ng/ml epidermal growth factor, 5 g/ml insulin, and 0.5% bovine pituitary extract. Cells in the third passage were used.
NT-4 Secretion. Keratinocytes (5 ϫ 10 4 /well) were seeded in triplicate into 24-well plates in 0.4 ml of KGM, adhered overnight, washed, and incubated with KBM including 1 M indomethacin for 24 h. The cells were washed and treated with the indicated concentrations of PGE 2 , sulprostone, or 1-OH PGE 1 in KBM, including indomethacin, for the indicated periods. The culture supernatants were assayed for NT-4 by enzyme-linked immunosorbent assay (R&D Systems, Minneapolis, MN). In some experiments, the keratinocytes were preincubated with signal inhibitors for 30 min before the addition of PGE 2 , sulprostone, or 1-OH PGE 1 .
Reverse Transcription-Polymerase Chain Reaction. The keratinocytes were incubated as above for the indicated periods, and then the total cellular RNA was extracted and reverse-transcribed to produce cDNA (Kanda and Watanabe, 2003) . The cDNA was thermocycled for polymerase chain reaction (PCR) as described previously (Kanda and Watanabe, 2003; Pang et al., 2003) . The primers for amplification and the sizes of the respective PCR products were as follows: NT-4, 5Ј-GCTGTGGACTTGCGTGG-3Ј and 5Ј-GCACAT-AGGACTG-3Ј for 209 bp; Sp1, 5Ј-ACAGGTGAGCTTGACCTCAC-3Ј and 5Ј-GTTGGTTTGCACCTGGTATG-3Ј for 370 bp; and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 5Ј-GCAGGGGGGAGC-CAAAAGGG-3Ј and 5Ј-TGCCAGCCCCAGCGTCAAAG-3Ј for 566 bp (Kü st et al., 2002; Kanda and Watanabe, 2003; Pang et al., 2003) . PCR was performed by one denaturing cycle at 95°C for 3 min, 30 cycles of denaturation at 95°C for 30 s, annealing at 58°C for 30 s, and extension at 72°C for 30 s, and a final extension at 72°C for 3 min. PCR products were analyzed by electrophoresis, and densitometric analysis was performed using ATTO lane analyzer version 3 (ATTO Corporation, Osaka, Japan). NT-4 or Sp1 mRNA levels were normalized to those of GAPDH.
mRNA Stability Analysis. The keratinocytes were treated with PGE 2 , sulprostone, or 1-OH PGE 1 for 8 h. RNA synthesis was blocked by actinomycin D (5 g/ml), and RNA was isolated 0, 1, 2, 4, 8, 16, and 32 h later. Reverse transcription (RT)-PCR was performed as described above, and the decay of mRNA was determined from the band density ratios of NT-4/GAPDH as described previously .
Plasmid and Transfection. Translucent Sp1 reporter vector (Luc Sp1) containing Sp1 enhancer elements (5Ј-ATTCGATCGGGGCGGG-GCGAGATTAGATTCGATCGGGGCGGGGCGAG-3Ј, consensus sequence underlined) in front of TATA box upstream of firefly luciferase reporter was purchased from Panomics (Redwood City, CA). Transient transfection was performed with FuGENE 6 (Roche Diagnostics, Indianapolis, IN) as described previously . The keratinocytes were plated in 35-mm dishes and grown to approximately 60% confluence. Luc Sp1 (1 g) and 0.2 g of herpes simplex virus thymidine kinase promoter-linked Renilla luciferase vector (phRL-TK) (Promega, Madison, WI) mixed with 3 l of FuGENE 6 was added to the keratinocytes. After 24 h, the cells were washed and incubated in KBM containing indomethacin for 24 h and then treated with PGE 2 , sulprostone, or 1-OH PGE 1 . After 24 h, the firefly and Renilla luciferase activities of the cell extracts were quantified using the dual luciferase assay system (Promega). Sp1 transcriptional activity was expressed as a ratio of firefly:Renilla luciferase activity.
Electrophoretic Mobility Shift Assay. Electrophoretic mobility shift assay (EMSA) was performed using an EMSA kit (Panomics) by incubating a biotin-labeled probe with a nuclear extract. The probe used was double-stranded oligonucleotide with consensus Sp1 sequence (5Ј-ATTCGATCGGGGCGGGGCGAGC-3Ј). The keratinocytes were pretreated with signal inhibitors for 30 min and then treated with PGE 2 , sulprostone, or 1-OH PGE 1 for 2 h. Nuclear extracts were obtained from the keratinocytes using a nuclear extraction kit (Panomics) according to the manufacturer's instructions. For the gel shift assays, 5 g of nuclear extracts were incubated with 10 ng of the labeled probe at room temperature for 30 min. Protein-DNA complexes were separated by 6% polyacrylamide gel and electrically transferred to a Biodyne B membrane (Pall Corporation, East Hills, NY) for chemiluminescence band detection. In the antibody supershift experiments, nuclear extracts were preincubated with rabbit polyclonal anti-Sp1 or Sp3 antibody (Santa Cruz Biotechnology, Santa Cruz, CA) for 30 min before the addition of the probe.
Treatment with Antisense Oligodeoxynucleotide. Antisense oligonucleotides against Sp1, Sp3, EP1, or EP3 proteins were synthesized as phosphorothioate-modified oligonucleotides and were high-pressure liquid chromatography-purified as described previously (Hata et al., 1998; Su et al., 2004) . The oligonucleotides were Sp1 (5Ј-ATATTAGGCATCACTCCAGG-3Ј), Sp3 (5Ј-AGTAGCAGCA-CTTGGAATCTGGACT-3Ј), EP1 (5Ј-GCAAGGGCTCATGTCAGGProstaglandin E 2 -Induced Neurotrophin-4 Production 797 at ASPET Journals on July 14, 2017 jpet.aspetjournals.org 3Ј), EP3 (5Ј-GTCTCCTTCATGTTGGC-3Ј), and control-scrambled (5Ј-AGTACCAGGACTTCGAATGTGCACT-3Ј). The keratinocytes were transfected with a final volume of 0.2 M of the indicated oligonucleotides premixed with FuGENE 6 in KGM for 24 h. The medium was aspirated, and the cells were cultured with KBM including indomethacin (1 M) for 24 h and then treated with PGE 2 , sulprostone, or 1-OH PGE 1 . In some experiments, these antisense oligonucleotides were transfected together with Luc Sp1 and phRL-TK.
Western Blotting. The phosphorylation of ERK was analyzed by Western blotting. The keratinocytes were pretreated with signal inhibitors for 30 min and then treated with PGE 2 , sulprostone, or 1-OH PGE 1 for 10 min. The cells were lysed, and equal amounts of whole-cell lysates (20 g/lane) were resolved by SDS-polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane. The membrane was blocked and incubated with anti-phospho-ERK1/2 or anti-ERK1/2 antibody (Santa Cruz Biotechnology) followed by peroxidase-conjugated secondary antibodies (Bio-Rad, Hercules, CA). The blots were developed using an enhanced chemiluminescence kit (GE Healthcare, Little Chalfont, Buckinghamshire, UK), and band intensity was measured by densitometric analysis.
The amount and phosphorylation status of Sp1 protein were also determined by Western blotting. The keratinocytes were treated with PGE 2 , sulprostone, or 1-OH PGE 1 for 2 h. The nuclear extracts were separated and electrophoretically resolved and then transferred to membranes. The membranes were incubated with anti-Sp1 or anti-Oct-1 antibody (Santa Cruz Biotechnology) and then with secondary antibodies and developed as described above.
The subcellular localization of PKC isoforms was examined as described previously . Nuclei and debris were removed from the whole-cell lysates by centrifugation (500g, 5 min), and this postnuclear fraction was centrifuged (10,500g, 90 min). The supernatant was saved as the cytosolic fraction. The pellet was homogenized in the same buffer, except that it contained 0.1% Triton X-100. The samples were mixed continuously for 1 h at 4°C and then centrifuged as described above. This supernatant was saved as the membrane fraction. Twenty micrograms of proteins of the cytosolic or membrane fractions were subjected to SDS-polyacrylamide gel electrophoresis and transferred as above, and the blots were incubated with anti-PKC␣, ␤I, ␤II, ␥, ␦, ⑀, , or antibodies (Santa Cruz Biotechnology) followed by secondary antibodies and developed as above. The antisense oligonucleotide-induced reduction in the respective protein levels was examined by Western blotting using the whole-cell lysates and anti-EP1 and EP3 antibodies (Cayman Chemical), anti-Sp1, Sp3, or GAPDH antibody (Santa Cruz Biotechnology), and secondary antibodies as described above.
Measurement of PGE 2 Release. The keratinocytes were incubated with KBM in the presence or absence of 1 M indomethacin for 48 h. The supernatant PGE 2 amount was measured by enzymelinked immunosorbent assay.
Statistical Analyses. Statistical evaluation of the results was performed by one-way analysis of variance using Dunnet's multiple comparison test for Fig. 1, A and B, or by one-way analysis of variance using Scheffe's multiple comparison test for Figs. 2B, 3B, 4A, 7A, and 7F. The results were considered significant at a value of P Ͻ 0.05.
Results
Enhancement of NT-4 Secretion and mRNA Expression by PGE 2 or Sulprostone. Constitutive PGE 2 release from the keratinocytes was 4.21 Ϯ 0.48 pmol/10 6 cells (mean Ϯ S.E.M., n ϭ 4). Cyclooxygenase inhibitor indomethacin (1 M) reduced PGE 2 release to an undetectable level (Ͻ0.36 pmol/10 6 cells) but did not reduce cell viability (Ͼ95% viable) or alter EP1, 2, 3, and 4 expression in the keratinocytes as determined by flow cytometry (data not shown). To avoid the influence of endogenous PGE 2 from the keratinocytes, further experiments were performed in the presence of indomethacin.
The keratinocytes constitutively secreted small amounts of NT-4 for 48 h (mean Ϯ S.E.M. 172.0 Ϯ 22.4 pg/10 6 cells, n ϭ 4), and the secretion was dose-dependently increased by PGE 2 or EP1/EP3 agonist sulprostone, whereas the secretion volume was not altered by EP2/EP4 agonist 1-OH PGE 1 (Fig. 1A) , indicating that EP1 or EP3 is involved in PGE 2 -induced NT-4 secretion. PGE 2 and sulprostone (10 Ϫ6 M) increased NT-4 secretion 9.9-and 10.3-fold compared with the controls, respectively. PGE 2 or sulprostone-induced increases in NT-4 secretion were abolished by cycloheximide (Fig. 1A) , indicating the requirement of de novo protein synthesis. A significant increase in NT-4 secretion compared with the controls was observed beginning 8 h after PGE 2 or sulprostone stimulation, increasing and continuing up to 48 h (Fig. 1B) .
To identify the PGE 2 receptor isoforms involved in NT-4 secretion, we studied whether antisense oligodeoxynucleotide against EP1 or EP3 suppresses PGE 2 or sulprostoneinduced NT-4 secretion. Antisense oligonucleotide against EP1 or EP3 selectively suppressed the expression of the respective receptor protein ( Fig. 2A) . Antisense EP3 suppressed PGE 2 or sulprostone-induced NT-4 secretion, but antisense EP1 or control-scrambled oligonucleotide did not (Fig. 2B) , indicating that EP3 but not EP1 is involved in PGE 2 or sulprostone-induced NT-4 secretion. We next examined whether PGE 2 or sulprostone increases NT-4 mRNA levels in the keratinocytes. At 8 h of incubation, PGE 2 and sulprostone increased NT-4 mRNA levels 6.9-and 7.6-fold compared with the controls, respectively, whereas the levels were not altered by 1-OH PGE 1 (Fig. 2C) . Antisense EP3 blocked PGE 2 , but antisense EP1 did not block PGE 2 or sulprostone-induced increases in NT-4 mRNA level, which paralleled the results for NT-4 secretion (Fig. 2B) . These results suggest that PGE 2 or sulprostone increases NT-4 production to pretranslational level via EP3.
We next examined whether PGE 2 or sulprostone increased the stability of NT-4 mRNA. The estimated half-life of NT-4 mRNA was mean Ϯ S.E.M. (n ϭ 4) 8.3 Ϯ 0.9 , 8.0 Ϯ 0.9, 8.2 Ϯ 0.8, and 8.2 Ϯ 0.9 h in the control, PGE 2 , sulprostone, and 1-OH PGE 1 (each 10 Ϫ6 M treated keratinocytes), respectively, and there were no significant differences in the comparison of either of the two groups (P Ͼ 0.05 by one-way analysis of variance using Scheffe's multiple comparison test). Thus, PGE 2 or sulprostone did not increase the stability of NT-4 mRNA, indicating that these agents enhance NT-4 production at the transcriptional level. 
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Involvement of Sp1 in PGE 2 or Sulprostone-Induced NT-4 Expression. Although human NT-4 promoter has not yet been completely identified, rat NT-4 transcription can be controlled by two promoters, a proximal promoter containing several Sp1-binding sites and a distal promoter containing two activator protein-1 (AP-1) sites (Salin et al., 1997) . Thus, we analyzed the involvement of transcription factors Sp1 or AP-1 in PGE 2 -induced NT-4 expression using specific inhibitors and antisense oligonucleotides. Treatment with antisense oligonucleotide against Sp1 or Sp3 selectively reduced the levels of phosphorylated (105 kDa) and nonphosphorylated (90 kDa) Sp1 and levels of large (100 kDa) and small (60 kDa) Sp3 isoforms, respectively (data not shown). Mithramycin A (an inhibitor of Sp1 binding to its GC-rich recognition sequence) or antisense Sp1 suppressed PGE 2 -induced NT-4 mRNA expression (Fig. 3A) and protein secretion (Fig. 3B) , whereas AP-1 inhibitor curcumin, control-scrambled oligonucleotide, or antisense Sp3 did not. Similar results were obtained when sulprostone was used instead of PGE 2 (data not shown). These results suggest that Sp1 is responsible, whereas AP-1 may be dispensable for PGE 2 or sulprostoneinduced NT-4 expression. We then analyzed whether PGE 2 or sulprostone enhances the transcriptional activity or DNA binding of Sp1.
Effects of PGE 2 or Sulprostone on the Transcriptional Activity, DNA Binding, Phosphorylation, and mRNA or Protein Levels of Sp1. PGE 2 or sulprostone enhances the transcriptional activity and DNA binding of Sp1. The keratinocytes were transiently transfected with luciferase vector linked to GC-rich Sp1 binding sequences in front of TATA box (Luc Sp1). PGE 2 or sulprostone increased Sp1-dependent transcriptional activity, whereas 1-OH PGE 1 did not (Fig. 4A) . Mithramycin A or antisense Sp1 suppressed PGE 2 -induced increases in Sp1 transcriptional activity, whereas antisense Sp3 or control oligonucleotide did not, supporting the existence of Sp1-specific activity. PGE 2 (Fig.  4A) or sulprostone-induced increases (data not shown) in Sp1 activity were suppressed by antisense EP3 but not by antisense EP1. These results suggest that PGE 2 or sulprostone increases Sp1-dependent transcriptional activity via EP3. EMSA was then performed using nuclear extracts and an oligonucleotide probe containing consensus GC-rich Sp1 binding sequences. At 2 h of incubation, PGE 2 (Fig. 4B, lane 2) or sulprostone (lane 3) increased the amount of DNAprotein complex with the Sp1 probe, whereas 1-OH PGE 1 did not alter the amount (lane 4). PGE 2 (Fig. 4B) or sulprostoneinduced increases (data not shown) in the complex were suppressed by antisense EP3 (lane 7) but not by antisense EP1 (lane 6). The DNA-protein complex induced by PGE 2 was completely abolished by mithramycin A (lane 8), and anti-Sp1 antibody supershifted the complexes (lanes 9 and 11) but anti-Sp3 antibody did not (lanes 10 and 12), indicating the presence of Sp1 in the complexes. These results suggest that PGE 2 or sulprostone enhances Sp1 binding to DNA via EP3.
We then investigated whether PGE 2 or sulprostone-induced Sp1 binding and transcriptional activity was due to increased Sp1 protein expression and/or post-translational modification. PGE 2 or sulprostone markedly increased the ratio between phosphorylated and nonphosphorylated Sp1 19.0-or 24.5-fold, respectively, compared with the controls (Fig. 5A) , whereas 1-OH-PGE 1 was much less potent at a 1.8-fold increase. PGE 2 (Fig. 5A ) or sulprostone-induced Sp1 phosphorylation (data not shown) was suppressed by antisense EP3 but not by antisense EP1. The total protein level of Sp1 in the nuclear extract was slightly increased by 84 and 55% after PGE 2 and sulprostone treatment, respectively (Fig.  5A) . In parallel to protein levels, PGE 2 and sulprostone modestly increased Sp1 mRNA levels by 222 and 169%, respectively (Fig. 5B) . The PGE 2 -induced increases in Sp1 protein (Fig. 5A ) and mRNA levels (Fig. 5B) were suppressed by antisense EP3 but not by antisense EP1. These results suggest that PGE 2 or sulprostone markedly enhances Sp1 phosphorylation and modestly increases mRNA and protein levels via EP3, and these effects may lead to the enhancement of Sp1 binding and transcriptional activity.
Involvement of the PI-PLC-PKC␣-MEK1-ERK Pathway in PGE 2 -Induced Sp1 Activation and NT-4 Production. It has been reported that the activation of EP1 or EP3 by PGE 2 is linked to the stimulation of PI-PLC, PKC, or ERK (Negishi et al., 1990 (Negishi et al., , 1995 Yano et al., 2002) , whereas the activation of EP2 or EP4 induces a cyclic AMP signal that stimulates protein kinase A (PKA) (Negishi et al., 1995; . The transcriptional activity of Sp1 is also stimulated by PKC, ERK, or PKA (Black et al., 2001) .
To know the signaling pathway(s) involved in PGE 2 or the sulprostone-induced activation of Sp1, we examined whether specific signaling enzyme inhibitors suppress the effects of these agents. PGE 2 -induced increases in Sp1 transcriptional activity (Fig. 6A) , DNA binding (Fig. 6B) , phosphorylation levels (Fig. 6C) , and in protein (Fig. 6C ) or mRNA levels (Fig. at ASPET Journals on July 14, 2017 jpet.aspetjournals.org Downloaded from 6D) were completely suppressed by PI-PLC inhibitor U73122, conventional PKC inhibitor Gö6976, and PD98059, which suppresses ERK by inhibiting MEK1 to phosphorylate ERK1/2. On the other hand, novel PKC inhibitor rottlerin or PKA inhibitor H-89 did not block the effects of PGE 2 on Sp1 levels and activities. Similar results were obtained when sulprostone was used instead of PGE 2 (data not shown). These results suggest that PI-PLC, conventional PKC, and MEK1 are responsible for PGE 2 or the sulprostone-induced activation of Sp1.
Because PGE 2 -induced NT-4 expression seemed to be mediated by Sp1, we analyzed whether signal inhibitors suppressing the PGE 2 -induced activation of Sp1 similarly suppressed PGE 2 -induced NT-4 expression. In parallel to the results for Sp1, PGE 2 -induced increases in NT-4 mRNA levels (Fig. 6E ) and protein secretion (Fig. 6F) were completely suppressed by U73122, Gö6976, and PD98059, whereas these were not altered by rottlerin or H-89. Similar results were obtained when sulprostone was used instead of PGE 2 (data not shown). These results suggest that PI-PLC, conventional PKC, and MEK1 are responsible for PGE 2 or the sulprostoneinduced expression of NT-4 as well as the activation of Sp1 by these agents.
MEK1 activates ERK via dual phosphorylation on threonine and tyrosine residues . Thus, we examined the phosphorylation status of ERK after treatment with PGE 2 or sulprostone. At 10 min, PGE 2 or sulprostone enhanced the dual phosphorylation of ERK1 (44 kDa) and ERK2 (42 kDa), whereas 1-OH PGE 1 did not (Fig.  7) . The total ERK1/2 levels were not altered by these agents. PGE 2 (Fig. 7) or sulprostone-induced ERK1/2 phosphorylation (data not shown) was suppressed by antisense EP3, U73122, Gö6976, and PD98059 while not suppressed by antisense EP1, rottlerin, or H-89. The results suggest that PGE 2 -induced ERK activation is mediated via EP3 and requires PI-PLC, conventional PKC, and MEK1 activities. Human keratinocytes express conventional PKC␣, novel PKC␦, ⑀, and , and atypical PKC (Reynolds et al., 1994) . The translocation of PKC from cytosol to membrane has been commonly accepted as an index of PKC activation (Reynolds et al., 1994) . Thus, we examined whether conventional PKC␣ is translocated from cytosol to membrane by PGE 2 or sulprostone. PGE 2 or sulprostone induced the membrane translocation of PKC␣ from cytosol (Fig. 8) . The membrane translocation of PKC␣ by PGE 2 was suppressed by U73122 and antisense EP3 but not by antisense EP1 (Fig. 8) . Other conventional PKC isoforms (PKC␤I, ␤II, or ␥) were not detected in the cytosol or membrane fractions from the keratinocytes (data not shown). The membrane translocation of PKC␦, ⑀, , and was not induced by PGE 2 or sulprostone (data not shown). The results suggest that PKC␣ is selectively activated by PGE 2 or sulprostone via EP3 and PI-PLC. Ϫ7 M) and then incubated with PGE 2 , sulprostone (Sul) or 1-OH PGE 1 (1-OH) (each 10 Ϫ6 M). After 24 h, relative luciferase activity was analyzed. The data are mean Ϯ S.E.M. of four separate experiments. ‫,ء‬ P Ͻ 0.05, significantly different from the control values; †, P Ͻ 0.05, significantly different from the values with PGE 2 alone. B, the keratinocytes were transfected with antisense oligonucleotides or preincubated with mithramycin A and incubated with PGE 2 , sulprostone, or 1-OH PGE 1 as above. After 2 h, nuclear extracts were obtained and EMSA was performed using an Sp1 probe. In the supershift assays, the nuclear extracts were incubated with anti-Sp1 or Sp3 antibody (Abs) for 30 min before the addition of the probe. The arrows indicate supershifted complexes. The results are representative of four separate experiments.
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Discussion
In this study, PGE 2 enhanced NT-4 production in keratinocytes via EP3 receptor. There have been no reports on the function of EP3 in neurotrophin production. Our findings thus suggest a novel key role of EP3 in NT-4 induction. EP3 may mediate NT-4 production in other cell types than keratinocytes and may play a neurotrophic role in tissues outside the skin. The stimulation of EP3 may also potentiate the production of other neurotrophins such as nerve growth factor or NT-3. We should further examine whether the activation of EP3 induces the production of these neurotrophins in human keratinocytes.
The EP3-mediated transcription of NT-4 was dependent on the activity of Sp1. Human NT-4 promoter has not been completely characterized; however, it may have several Sp1-binding sites because antisense Sp1 suppressed NT-4 expression. Further studies should identify the Sp1 elements responsible for human NT-4 transcription.
The EP3-mediated the transcriptional activity and DNA binding of Sp1 (Fig. 4, A and B) positively correlated with its phosphorylation level (Fig. 5A) , indicating that phosphorylation may potentiate the transcriptional activity of Sp1. The phosphorylation of Sp1 may dissociate transcriptional repressor(s) from Sp1, such as Sp1-I and p74, which inhibits the DNA binding and transcriptional activity of Sp1, respectively (Chen et al., 1994; Murata et al., 1994) , or from Sp1-bound promoter, such as histone deacetylase 1 (Choi et al., 2002) . Alternatively, the phosphorylation of Sp1 may recruit transcriptional coactivators such as p300 or enhance its interaction with basal transcriptional machinery such as dTAF II 110 (Gill et al., 1994) . Ϫ6 M), Gö6976 (Gö; 10 Ϫ8 M), rottlerin (Rott; 10 Ϫ6 M), PD98059 (PD; 10 Ϫ5 M), or H-89 (10 Ϫ7 M) and then incubated with PGE 2 (10 Ϫ6 M). After 24 h, luciferase activity was analyzed. B, C, D, E, and F, keratinocytes without transfection were preincubated with inhibitors and then incubated with PGE 2 as above. At 2 h, the nuclear extracts were subjected to EMSA using an Sp1 probe (B) or blotted with anti-Sp1 or Oct-1 antibody (C). The band intensity ratio of phosphorylated Sp1 (pSp1)/nonphosphorylated Sp1 was corrected to that in the control (set as 1.0). The band intensity ratio of total Sp1 (phosphorylated and nonphosphorylated Sp1)/Oct-1 was corrected to that in the control. At 2 (D) or 8 h (E), RNA was subjected to RT-PCR, and Sp1 (D) or NT-4 (E) mRNA levels were normalized to those of GAPDH and are shown as a -fold induction. At 48 h, the culture supernatants were analyzed for NT-4 secretion (F). The results in B, C, D, and E are representative of four separate experiments. The data in A and F are mean Ϯ S.E.M. of four separate experiments. ‫,ء‬ P Ͻ 0.05, significantly different from the control values; †, P Ͻ 0.05, significantly different from values with PGE 2 alone. 5 . Enhancement of Sp1 phosphorylation and increases in Sp1 protein or mRNA levels induced by PGE 2 or sulprostone. The keratinocytes were transfected with antisense oligonucleotide (AS) against Sp1, Sp3, or control-scrambled oligonucleotide (Con) (each 0.2 M) and then incubated with PGE 2 , sulprostone (Sul), or 1-OH PGE 1 (1-OH) (each 10 Ϫ6 M) for 2 h. A, the nuclear extracts were blotted with anti-Sp1 or Oct-1 antibody. The band intensity ratio of phosphorylated Sp1 (pSp1)/nonphosphorylated Sp1 was corrected to that in the control (set as 1.0). The band intensity ratio of total Sp1 (phosphorylated and nonphosphorylated Sp1)/Oct-1 was corrected to that in the control. B, RNA was subjected to RT-PCR, and Sp1 mRNA levels were normalized to those of GAPDH and are shown as a -fold induction. The results shown are representative of four separate experiments.
The stimulation of EP3 by PGE 2 activated ERK (Fig. 7) , and this kinase was essential for the phosphorylation and transcriptional activity of Sp1 (Fig. 6 ). It has also been reported that the activation of ERK leads to the enhancement of the phosphorylation and DNA binding of Sp1 in human gastric adenocarcinoma cells (Merchant et al., 1999) . Because Sp1 contains six putative ERK phosphorylation sites (Merchant et al., 1999) , ERK may directly phosphorylate and activate Sp1 in PGE 2 -stimulated keratinocytes. Alternatively, kinase(s) downstream of ERK may phosphorylate Sp1 in these cells. Further studies should identify direct Sp1 kinase induced by PGE 2 and phosphorylation sites on Sp1. In parallel to the enhanced phosphorylation of Sp1 (Fig. 5A) , the protein and mRNA levels of Sp1 were increased by PGE 2 (Fig. 5, A and B) , although the magnitude of the increased expression (approximately 2-or 3-fold compared with the controls) was much lower compared with that of phosphorylation (approximately 20-fold). It is possible that the increased expression of Sp1 may just result from the enhanced phosphorylation of Sp1, because Sp1 promoter itself contains several Sp1-binding elements and is positively regulated by its own gene product, Sp1 protein (Nicolas et al., 2001) .
The activation of ERK via EP3 depended on the activity of PI-PLC and conventional PKC in the keratinocytes (Fig. 7) . EP3 is linked to PI-PLC, and PI-PLC generates diacylglycerol, which activates conventional and novel PKCs (Negishi et al., 1990) . The stimulation of EP3 by PGE 2 led to the activation of conventional PKC␣ dependently on PI-PLC in human keratinocytes (Fig. 8) . PKC␣ was also activated by PGE 2 via PI-PLC in rat osteoblasts in vitro (Tang et al., 2005) . On the other hand, in the medullary thick ascending limb of rat kidney, novel PKC␦ was activated by PGE 2 in vitro only in the presence of arginine vasopressin, whereas PKC␣ was not (Aristimuno and Good, 1997) . PGE 2 in vivo activated novel PKC⑀ in rat colonic mucosa (Conte et al., 2004) . Thus, PKC isoforms activated by PGE 2 may vary according to cell type, species, or experimental conditions and may reflect the relative expression, activity, or intracellular compartmentalization of individual PKC isoforms. PKC␣ phosphorylates and activates c-Raf (Kolch et al., 1993) , and the activated c-Raf may further phosphorylate and activate MEK1 that catalyzes the phosphorylation of ERK. Thus, the activation of EP3 may trigger the signaling cascade of PI-PLC-PKC␣-c-Raf-MEK1-ERK, resulting in the activation of Sp1. EP1 is also linked to the PI-PLC-PKC pathway in rat growth-zone chondrocytes (Sylvia et al., 2001) or linked to the activation of ERK in rat kidney mesangial cells (Suganami et al., 2001 ). However, antisense EP1 did not suppress the PGE 2 -induced activation of PKC␣ (Fig. 8) or ERK (Fig. 7) in human keratinocytes, indicating EP1-independent effects. This is possibly because the expression level and/or PGE 2 affinity of EP1 are much lower than those of EP3 in human keratinocytes .
EP2/EP4 agonist 1-OH PGE 1 slightly increased the phosphorylation, mRNA, or protein levels of Sp1 (Fig. 5, A and B) ; however, it did not significantly increase the DNA binding and transcriptional activity of Sp1 (Fig. 4, A and B) or expression of NT-4 ( Figs. 1 and 2 ). EP2 or EP4 is linked to PKA , and Sp1 can be phosphorylated and activated by PKA (Black et al., 2001) . Thus, PKA activated by 1-OH PGE 1 via EP2 or EP4 may phosphorylate Sp1. However, the phosphorylation level may be less than the threshold for driving the Sp1-dependent transcription of NT-4. The kinase(s) activating Sp1 may vary according to cell type or stimuli and reflect the relative activities of the signaling molecules in the target cells.
Our present findings indicate that PGE 2 in vivo promotes skin innervation via the induction of NT-4, especially in lesions with atopic dermatitis associated with elevated PGE 2 levels. The level of PGE 2 released from keratinocytes in vitro (4.21 pmol/10 6 cells, corresponding to approximately 0.52 nM) was less than the threshold (10 nM) for NT-4 induction (Fig. 1A) and may not enhance NT-4 production per se. However, in skin lesions with atopic dermatitis, more than the threshold levels of PGE 2 might be released from neighboring cells such as macrophages or mast cells infiltrating the lesions (Imayama et al., 1995; Kiekens et al., 2001) . In atopic skin lesions, the amounts of proinflammatory cytokines, tumor necrosis factor-␣, interleukin-1, or interferon-␥ may be increased and this may promote PGE 2 release from the Fig. 7 . Enhancement of ERK1/2 phosphorylation by PGE 2 or sulprostone. The keratinocytes were transfected with antisense oligonucleotide (AS) against EP1, EP3, or control-scrambled oligonucleotide (Con) (each 0.2 M) or preincubated with U73122 (U; 10 Ϫ6 M), Gö6976 (Gö; 10 Ϫ8 M), rottlerin (Rott; 10 Ϫ6 M), PD98059 (PD; 10 Ϫ5 M), or H-89 (10 Ϫ7 M) and then incubated with PGE 2 , sulprostone (Sul), or 1-OH PGE 1 (1-OH) (each 10 Ϫ6 M) for 10 min. The wholecell lysates were blotted with anti-phospho-ERK antibody (A) or anti-ERK (B) antibody. Phosphorylated ERK (p-ERK) or total ERK levels are corrected to those in the control (set as 1.0). The results shown are representative of four separate experiments. jpet.aspetjournals.org neighboring cells by inducing the expression of cyclooxygenase-2 (Takayama et al., 2002) . Thus, in skin lesions with atopic dermatitis, PGE 2 from cells neighboring keratinocytes may act on EP3 on keratinocytes and promote the synthesis and secretion of NT-4. The secreted NT-4 may support the survival and sprouting of nerve fibers, especially sensory C-fibers, and thus sustain a pruritic sensation. In addition, the secreted NT-4 may modulate skin inflammation by regulating the survival or activity of macrophages, mast cells, eosinophils, or T cells containing trkB or p75NTR. PGE 2 in skin lesions with atopic dermatitis thus may contribute to cross-talk between the immune and nervous systems by the induction of NT-4. We should further examine whether the topical addition of PGE 2 enhances NT-4 expression in the keratinocytes of skin lesions with atopic dermatitis and whether antisense oligonucleotide against EP3 blocks the effects of PGE 2 . EP3 may be a novel therapeutic target for atopic dermatitis.
